Methylphenidate and Fludara drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Fludara (fludarabine phosphate). Common drug interactions include kidney infection among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Fludara. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.



On Jul, 19, 2026

13 people who take Methylphenidate and Fludara together, and have interactions are studied.

Methylphenidate and Fludara drug interactions.

What are the common drug interactions of Methylphenidate and Fludara, by gender? *:

female:

  1. Kidney infection
  2. Clostridium test positive
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

male:

  1. Pyrexia (fever)
  2. Adenovirus infection
  3. Cellulitis (infection under the skin)
  4. Cerebellar infarction (impaired blood circulation to cerebellum)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Hypoxia (low oxygen in tissues)
  7. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  8. Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
  9. Staphylococcal bacteraemia (a bacterial infection of blood)
  10. Bone marrow failure

What are the common drug interactions of Methylphenidate and Fludara, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Headache (pain in head)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bone marrow failure
  2. Cystitis haemorrhagic (blood in the urine and painful voiding)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Haematuria (presence of blood in urine)
  5. Pyrexia (fever)
  6. Adenovirus infection

50-59:

n/a

60+:

  1. Kidney infection
  2. Clostridium test positive
  3. Cellulitis (infection under the skin)
  4. Cerebellar infarction (impaired blood circulation to cerebellum)
  5. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  6. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  7. Hypotension (abnormally low blood pressure)
  8. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  9. Staphylococcal bacteraemia (a bacterial infection of blood)

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 10 people, 76.92%
  2. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 5 people, 38.46%
  3. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 30.77%
  4. Tumor Pain: 3 people, 23.08%
  5. Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 23.08%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 23.08%
  7. Haematopoietic Stem Cell Mobilisation: 3 people, 23.08%
  8. Hypersensitivity: 2 people, 15.38%
  9. Adjustment Disorder With Anxiety: 2 people, 15.38%
  10. Allergic Rhinitis: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Fludara?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylphenidate and Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fludara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate and fludarabine phosphate (the active ingredients of Methylphenidate and Fludara, respectively), and Methylphenidate and Fludara (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: